Nepafenac

Records for this ingredient, by country (identity only).

ATC S01BC10 · 11 markets · 29 records

Nepafenac 11 markets · 29 records Forms
Filters
MarketGB 4ES 4US 3AU 3CA 2TW 2HK 2SG 1JP 1EU 1

GB 4 records · 2 shown of 2 Source NHSBSA dm+d · Data as of 2026-10-19

ES 4 records · 2 shown of 2 Source CIMA (AEMPS) · Data as of live

US 3 records · 2 shown of 2 Source openFDA NDC Directory · Data as of 2026-10-23

  • 3 mg per mL / per unit basis not statedliquidILEVRO
  • 1 mg per mL / per unit basis not statedliquidNEVANAC

AU 3 records · 1 shown of 1 Source TGA、TGA CMI repository (consumer medic · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 3 mg/mL per mL / per unit basis not statedliquidILEVRO nepafenac 0.3% eye drops, suspension, bottleILEVRO nepafenac 0.3% eye drops, suspension, oval bottle unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名ILEVRO ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

CA 2 records · 2 shown of 2 Source Health Canada Drug Product Databas · Data as of 2026-10-23

  • 0.3 % per mL / per unit basis not statedliquidILEVRO
  • 0.1 % per mL / per unit basis not statedliquidNEVANAC

TW 2 records · 1 shown of 1 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Nevanac Ophthalmic suspension 0.1% ×1納衛視點眼懸液劑 0.1% ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

HK 2 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名NEVANAC OPHTHALMIC SUSP 0.1%W/V ×1NEVANAC OPHTHALMIC SUSPENSION 0.1% W/V ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

  • 1 mg/mL per mL / per unit basis not statedliquidNevanac® Eye Drops Suspension 1 mg/ml

JP 1 records · 1 shown of 1 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

  • 0.1 %/1 mLophthalmicネバナック懸濁性点眼液0.1%

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名NEVANAC ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.